Logo Logo

Publications by Dempke, Wolfram C. M.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 5.

Journal article

Dempke, Wolfram C. M.; Fenchel, Klaus; Uciechowski, Peter; Dale, Stephen P. (2017): Second- and third-generation drugs for immuno-oncology treatment-The more the better? In: European Journal of Cancer, Vol. 74: pp. 55-72

Dempke, Wolfram C. M.; Fenchel, Klaus; Uciechowski, Peter; Chevassut, Timothy (2017): Targeting Developmental Pathways: The Achilles Heel of Cancer? In: Oncology, Vol. 93, No. 4: pp. 213-223

Fenchel, Klaus; Dale, Stephen P.; Dempke, Wolfram C. M. (2016): Improved overall survival following tyrosine kinase inhibitor (TKI) treatment in NSCLC-are we making progress? In: Translational Lung Cancer Research, Vol. 5, No. 4: pp. 373-376

Dempke, Wolfram C. M.; Fenchel, Klaus (2016): Pembrolizumab as first-line treatment for non-small cell lung cancer-a game changer? In: Translational Lung Cancer Research, Vol. 5, No. 5: pp. 538-542

Fenchel, Klaus; Sellmann, Ludger; Dempke, Wolfram C. M. (2016): Overall survival in non-small cell lung cancer-what is clinically meaningful? In: Translational Lung Cancer Research, Vol. 5, No. 1: pp. 115-119

This list was generated on Mon Sep 23 07:06:19 2019 CEST.